InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,999.00
(
0.43%
)
US TECH 100
20,555.20
(
0.07%
)
Dow Jones
44,008.76
(
0.64%
)
Brent Oil
73.82
(
-2.18%
)
Bitcoin
76,514.44
(
0.81%
)
TVTX logo
TVTX
Travere Therapeutics, Inc.
NASDAQ
Add Alert
Follow
2
TVTX logo
TVTX
Travere Therapeutics, Inc.
NASDAQ
Add Alert
Follow
2
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up
Live Updating
profile icon
Monksdream PremiumMember
09/08/24 12:54 PM
Post #10
Last Read
profile icon
Monksdream PremiumMember
07/04/24 10:25 AM
Post #9
Last Read
profile icon
tw0122 Free
05/07/24 10:41 AM
Post #8
Re: #7: @Monksdream - TVTX under $10
Last Read
profile icon
Monksdream PremiumMember
04/28/24 6:33 PM
Post #7
Last Read
profile icon
bikaver Free
11/01/23 6:06 PM
Post #6
Bullish
Bullish
Last Read
profile icon
bikaver Free
09/29/23 5:14 PM
Post #5
Re: #4: @bikaver - TVTX.....Gambling on a dead cat bounce.....in @ 7.65 AH.
Last Read
profile icon
bikaver Free
09/21/23 5:13 PM
Post #4
Last Read
profile icon
Stockexpertpro Free
09/21/23 8:39 AM
Post #3
Bearish
Bearish
Last Read
profile icon
alchemytrader Free
08/17/21 7:56 PM
Post #2
Re: #1: @cash4 - Free Martin Shkreli, LMFAO, felon CEO with a
Last Read
profile icon
cash4 Free
02/05/21 12:12 AM
Post #1
Last Read

Travere Therapeutics, Inc. (TVTX) RSS Feed

Followers
2
Posters
6
Posts (Today)
0
Posts (Total)
10
Created
02/04/21
Type
Free
Moderators
 

TVTX

Travere Therapeutics, Inc.

 
DESCRIPTION
Retrophin, Inc. (OTCQB: RTRX) New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy (DMD), and Spinal Muscular Atrophy (SMA).
 
 
TVTX SECURITY DETAILS

Share Structure

 
 
Market Cap Market Cap
1,547,540,059
02/03/2021
Authorized Shares
100,000,000
03/05/2013
Outstanding Shares
50,905,923
07/29/2020
Restricted
Not Available
 
Unrestricted
Not Available
 
Held at DTC
Not Available
 
Float
8,280,000
03/05/2013
Par Value
0.0001
 

TRAVERE THERAPEUTICS, INC.

3611 Valley Centre Drive

Suite 300

San Diego, CA 92130
Volume:
Day Range:
Last Trade Time:
Delayed by 15 minutes
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
TVTX Latest News
More TVTX News
New Post